ArticleBMC medical research methodology2025
Assessing the quality for integrated guidelines: systematic comparison between the AGREE Ⅱ and AGREE-HS tools.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Nutritional Risk Screening Recommendations for Critically Ill Patients: A Meta-Research Study and Quality Appraisal of Clinical Guidelines.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis study evaluates WHO guidelines, particularly those integrating health systems guidance (HSG) and clinical practice guideline (CPG), by comparing the AGREE Ⅱ and AGREE-HS tools to identify differences in assessing integrated guidelines (IGs).
methodsThis exploratory evaluation used WHO epidemic guidelines. A comprehensive search in the WHO Institutional Repository for Information Sharing (IRIS) identified CPGs, HSGs, and IGs, which were assessed using AGREE Ⅱ and/or AGREE-HS tools.
resultsA total of 157 guidelines (20 CPGs, 101 HSGs, and 36 IGs) were included. CPGs scored significantly higher than IGs with AGREE Ⅱ (P < 0.001), but no significant difference was found using AGREE-HS (P = 0.185). Significant differences were found in multiple domains of AGREE Ⅱ (P < 0.05), including Scope and Purpose, Stakeholder Involvement, and Editorial Independence. AGREE-HS also revealed differences in cost-effectiveness and ethical criteria (P < 0.05).
conclusionCPGs were of significantly higher quality than IGs when assessed with AGREE Ⅱ, while IGs and HSGs showed similar quality with AGREE-HS. Despite consistent overall scores for IGs across both tools, specific item scores varied. These findings underscore the need for more transparent reporting in IGs, particularly regarding developer information, conflicts of interest, and patient guidance. Future work should focus on developing tools that integrate both AGREE Ⅱ and AGREE-HS to improve guideline evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.